EU adaptive licensing pilot makes good progress: seven drugs under discussion
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's pilot adaptive licensing project is gathering pace, with 26 product candidates submitted to date, and seven having been selected for discussion with the companies concerned. The adaptive licensing discussion group (ALDG) has so far held three meetings, including three teleconferences with applicants about specific development programs.